Sanara MedTech Inc. (SMTI) vs Turn Therapeutics Inc. (TTRX)
A side-by-side comparison of Sanara MedTech Inc. and Turn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SMTI
Sanara MedTech Inc.
$35.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TTRX
Turn Therapeutics Inc.
$11.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SMTI vs TTRX
growth of $100 · dividends reinvested · last 1ySMTI +15.4% (+15.4%/yr)TTRX +76.6% (+76.6%/yr)TTRX compounded faster over this window
SMTI TTRX
SMTI vs TTRX: by the numbers
- •TTRX is the larger company ($347M vs $322M market cap).
- •Both run net losses; TTRX's is the smaller (0.00% vs -29.15% net margin).
Metrics side by side
Valuation
| Metric | SMTI | TTRX |
|---|---|---|
| Forward P/E | 184.21 | N/A |
| P/S ratio | 2.93 | N/A |
| P/B ratio | 40.51 | 504.79 |
| EV / EBITDA | 27.80 | N/A |
| FCF yield | 1.40% | N/A |
Profitability
| Metric | SMTI | TTRX |
|---|---|---|
| Gross margin | 91.33% | 0.00% |
| Operating margin | 9.36% | 0.00% |
| Net margin | -29.15% | 0.00% |
| ROE | -403.03% | -1229.58% |
| ROIC | 18.15% | -84.66% |
Growth (annualized)
| Metric | SMTI | TTRX |
|---|---|---|
| Revenue CAGR (5Y) | 40.06% | N/A |
| Total return CAGR (5Y) | 0.35% | N/A |
Go deeper
Dig into the metrics
Sanara MedTech ROETurn Therapeutics ROESanara MedTech operating marginTurn Therapeutics operating marginSanara MedTech revenue growthTurn Therapeutics revenue growthSanara MedTech free cash flowTurn Therapeutics free cash flow
Sanara MedTech & Turn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.